COYA
Price
$5.85
Change
-$0.05 (-0.85%)
Updated
Jun 27 closing price
Capitalization
97.84M
43 days until earnings call
SNDX
Price
$9.04
Change
-$0.26 (-2.80%)
Updated
Jun 27 closing price
Capitalization
777.87M
42 days until earnings call
Interact to see
Advertisement

COYA vs SNDX

Header iconCOYA vs SNDX Comparison
Open Charts COYA vs SNDXBanner chart's image
Coya Therapeutics
Price$5.85
Change-$0.05 (-0.85%)
Volume$94.81K
Capitalization97.84M
Syndax Pharmaceuticals
Price$9.04
Change-$0.26 (-2.80%)
Volume$3.24M
Capitalization777.87M
COYA vs SNDX Comparison Chart in %
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. SNDX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Buy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (COYA: $5.85 vs. SNDX: $9.04)
Brand notoriety: COYA and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 195% vs. SNDX: 138%
Market capitalization -- COYA: $97.84M vs. SNDX: $777.87M
COYA [@Biotechnology] is valued at $97.84M. SNDX’s [@Biotechnology] market capitalization is $777.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, COYA is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 4 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 4 bullish, 3 bearish.
  • SNDX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both COYA and SNDX are a good buy in the short-term.

Price Growth

COYA (@Biotechnology) experienced а +6.27% price change this week, while SNDX (@Biotechnology) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

COYA is expected to report earnings on Aug 12, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($778M) has a higher market cap than COYA($97.8M). COYA YTD gains are higher at: 2.094 vs. SNDX (-31.619). COYA has higher annual earnings (EBITDA): -19.42M vs. SNDX (-318.27M). SNDX has more cash in the bank: 516M vs. COYA (35.5M). SNDX has higher revenues than COYA: SNDX (43.7M) vs COYA (3.69M).
COYASNDXCOYA / SNDX
Capitalization97.8M778M13%
EBITDA-19.42M-318.27M6%
Gain YTD2.094-31.619-7%
P/E RatioN/AN/A-
Revenue3.69M43.7M8%
Total Cash35.5M516M7%
Total DebtN/A1.84M-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYASNDX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 14 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAMNX11.060.06
+0.55%
Gabelli Global Mini Mites AAA
OCSVX10.460.04
+0.38%
Optimum Small-Mid Cap Value C
HSMVX12.570.04
+0.32%
Hartford Small Cap Value R6
AEYIX8.580.02
+0.23%
American Century Equity Income C
TRVHX17.85N/A
N/A
Nuveen Mid Cap Value I

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-0.85%
KNSA - COYA
40%
Loosely correlated
-1.58%
NTLA - COYA
36%
Loosely correlated
-0.52%
EYPT - COYA
35%
Loosely correlated
-7.04%
SNDX - COYA
34%
Loosely correlated
-2.80%
TRDA - COYA
34%
Loosely correlated
-1.57%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with CGON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-2.80%
CGON - SNDX
53%
Loosely correlated
-0.46%
REPL - SNDX
52%
Loosely correlated
N/A
IDYA - SNDX
52%
Loosely correlated
-4.13%
ETNB - SNDX
50%
Loosely correlated
-0.90%
RNA - SNDX
50%
Loosely correlated
-2.68%
More